Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy

Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2008, Vol.14 (1), p.199-208
Hauptverfasser: WYKOSKY, Jill, GIBO, Denise M, STANTON, Constance, DEBINSKI, Waldemar
Format: Artikel
Sprache:eng
Schlagworte:
Antineoplastic agents
Biological and medical sciences
Medical sciences
Neurology
Pharmacology. Drug treatments
Tumors of the nervous system. Phacomatoses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 208
container_issue 1
container_start_page 199
container_title Clinical cancer research
container_volume 14
creator WYKOSKY, Jill
GIBO, Denise M
STANTON, Constance
DEBINSKI, Waldemar
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_20145591</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20145591</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_201455913</originalsourceid><addsrcrecordid>eNqNj01OwzAUhCMEEuXnDm_DDktxElNYRqWli7Ip2VcP5zkxOLZlu4schyNwEc6EERyA1cxivhnNSbHgQixZXd2J0-zL5T0rm7o6Ly5ifCtL3vCyWRQfO5soGDq-a8t4DXuS5JML8PVZ3cLaj20WtD1sXGR7Mpioh9YmPZAFDhjh2RmSR4MBHsm6SVvMeASnYKuHkT0F7AnamIKTc3JTJn7qXjxJrbSEDsNAKYLKmys3vf7yGg10IwX081VxptBEuv7Ty-Jms-5WW-YxSjQqoJU6HnzQE4b5UOVnQjzw-r-5b91bXr4</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy</title><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>WYKOSKY, Jill ; GIBO, Denise M ; STANTON, Constance ; DEBINSKI, Waldemar</creator><creatorcontrib>WYKOSKY, Jill ; GIBO, Denise M ; STANTON, Constance ; DEBINSKI, Waldemar</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Medical sciences ; Neurology ; Pharmacology. Drug treatments ; Tumors of the nervous system. Phacomatoses</subject><ispartof>Clinical cancer research, 2008, Vol.14 (1), p.199-208</ispartof><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20145591$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>WYKOSKY, Jill</creatorcontrib><creatorcontrib>GIBO, Denise M</creatorcontrib><creatorcontrib>STANTON, Constance</creatorcontrib><creatorcontrib>DEBINSKI, Waldemar</creatorcontrib><title>Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy</title><title>Clinical cancer research</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Tumors of the nervous system. Phacomatoses</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqNj01OwzAUhCMEEuXnDm_DDktxElNYRqWli7Ip2VcP5zkxOLZlu4schyNwEc6EERyA1cxivhnNSbHgQixZXd2J0-zL5T0rm7o6Ly5ifCtL3vCyWRQfO5soGDq-a8t4DXuS5JML8PVZ3cLaj20WtD1sXGR7Mpioh9YmPZAFDhjh2RmSR4MBHsm6SVvMeASnYKuHkT0F7AnamIKTc3JTJn7qXjxJrbSEDsNAKYLKmys3vf7yGg10IwX081VxptBEuv7Ty-Jms-5WW-YxSjQqoJU6HnzQE4b5UOVnQjzw-r-5b91bXr4</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>WYKOSKY, Jill</creator><creator>GIBO, Denise M</creator><creator>STANTON, Constance</creator><creator>DEBINSKI, Waldemar</creator><general>American Association for Cancer Research</general><scope>IQODW</scope></search><sort><creationdate>2008</creationdate><title>Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy</title><author>WYKOSKY, Jill ; GIBO, Denise M ; STANTON, Constance ; DEBINSKI, Waldemar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_201455913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Tumors of the nervous system. Phacomatoses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WYKOSKY, Jill</creatorcontrib><creatorcontrib>GIBO, Denise M</creatorcontrib><creatorcontrib>STANTON, Constance</creatorcontrib><creatorcontrib>DEBINSKI, Waldemar</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WYKOSKY, Jill</au><au>GIBO, Denise M</au><au>STANTON, Constance</au><au>DEBINSKI, Waldemar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy</atitle><jtitle>Clinical cancer research</jtitle><date>2008</date><risdate>2008</risdate><volume>14</volume><issue>1</issue><spage>199</spage><epage>208</epage><pages>199-208</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2008, Vol.14 (1), p.199-208
issn 1078-0432
1557-3265
language eng
recordid cdi_pascalfrancis_primary_20145591
source American Association for Cancer Research; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Antineoplastic agents
Biological and medical sciences
Medical sciences
Neurology
Pharmacology. Drug treatments
Tumors of the nervous system. Phacomatoses
title Lnterleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A36%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lnterleukin-13%20Receptor%20%CE%B12,%20EphA2,%20and%20Fos-Related%20Antigen%201%20as%20Molecular%20Denominators%20of%20High-Grade%20Astrocytomas%20and%20Specific%20Targets%20for%20Combinatorial%20Therapy&rft.jtitle=Clinical%20cancer%20research&rft.au=WYKOSKY,%20Jill&rft.date=2008&rft.volume=14&rft.issue=1&rft.spage=199&rft.epage=208&rft.pages=199-208&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E20145591%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true